| What are the treatment options for high-grade dysplasia in Barrett's esophagus? |
|
Begg CB, Cramer LD, Hoskins WJ, Brennan MF. Impact of hospital volume on operative mortality for major cancer surgery. Jama 1998; 280(20):1747-51. |
|
Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I, Welch HG, Wennberg DE. Hospital volume and surgical mortality in the United States. The New England Journal of Medicine 2002; 346(15):1128-37. |
|
Bolton JS, Fuhrman GM, Richardson WS. Esophageal resection for cancer. Surgical Clinics of North America 1998; 78(5):773-94. |
|
Buttar NS, Wang KK, Sebo TJ, Riehle DM, Krishnadath KK, Lutzke LS, Anderson MA, Petterson TM, Burgart LJ. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology 2001; 120(7):1630-9. |
|
Cameron AJ. Management of Barrett's esophagus. Mayo Clinic Proceedings 1998; 73(5):457-61. |
|
Collard JM, Romagnoli R, Hermans BP, Malaise J. Radical esophageal resection for adenocarcinoma arising in Barrett's esophagus. American Journal of Surgery 1997; 174(3):307-11. |
| Dulai GS, Jensen DM,
Cortina G, Fontana L, Ippoliti A. Randomized trial of argon plasma
coagulation vs. multipolar electrocoagulation for ablation of
Barrett's esophagus. Gastrointestinal Endoscopy 2005;61:232-40. |
|
Edwards M, Gable D, Lentsch A. The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia. Annals of Surgery 1996; 223:585-591. |
|
Ellis FHJ, Heatley GJ, Krasna MJ, Williamson WA, Balogh K. Esophagogastrectomy for carcinoma of the esophagus and cardia: a comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria. Journal of Thoracic and Cardiovascular Surgery 1997; 113(5):836-46; discussion 846-8.` |
| Eisen G. Ablation
therapy for Barrett's esophagus. Gastrointestinal Endoscopy 2003;
58:760-8. |
|
Falk G. Unresolved issues in Barrett's esophagus in the new millennium. Digestive Diseases 2000; 18(1):27-42. |
|
Falk GW, Rice TW, Goldblum JR, Richter JE. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. Gastrointestinal Endoscopy 1999; 49(2):170-6. |
| Ganz RA, Utley DS,
Stern RA, Jackson J, Batts KP, Termin P. Complete
ablation of esophageal epithelium with a balloon-based bipolar
electrode: a phased evaluation in the porcine and in the human
esophagus. Gastrointestinal Endoscopy 2004; 60:1002-10. |
| Johnston MH, Eastone
JA, Horwhat JD, Cartledge J, Mathews JS, Foggy JR. Cryoablation of
Barrett's esophagus: a pilot study. Gastrointestinal Endoscopy
2005; 62:842-8. |
|
Karl RC, Schreiber R, Boulware D, Baker S, Coppola D. Factors affecting morbidity, mortality, and survival in patients undergoing Ivor Lewis esophagogastrectomy. Annals of Surgery 2000; 231(5):635-43. |
|
Krishnadath KK, Wang KK, Taniguchi K, Sebo TJ, Buttar NS, Anderson MA, Lutzke LS, Liu W. Persistent genetic abnormalities in Barrett's esophagus after photodynamic therapy. Gastroenterology 2000; 119(3):624-30. |
|
Levine DS, Haggitt RC, Blount PL, Rabinovitch PS, Rusch VW, Reid BJ. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 1993; 105(1):40-50. |
|
Levine DS, Haggitt, C.R., Irvine, S., Reid, B.J. Natural History of high-grade dysplasia In Barrett's Esophagus. Gastroenterology 1996; 110(4):A550. |
|
Levine DS. Barrett's esophagus update: management of Barrett's esophagus. Issues and Insights 1996; 5:6-8. |
|
Levine DS. Management of dysplasia in the columnar-lined esophagus. Gastroenterology Clinics of North America 1997; 26(3):613-34. |
|
Lim KN, Waring PJ, Saidi R. Therapeutic options in patients with Barrett's esophagus. Digestive Diseases 1999; 17(3):145-52. |
| Overholt BF, Lightdale
CJ, Wang KK, Canto MI, Burdick S, Haggitt RC, Bronner MP, Taylor
SL, Grace MG, Depot M; International Photodynamic Group for
High-Grade Dsyplasia in Barrett's Esophagus. Phtodynamic therapy
with porfimer sodium for ablation of high-grade dysplasia in
Barrett's esophagus; international, partially blinded, randomized
phase III trial. Gastrointestinal Endoscopy 2005; 62: 488-98. |
| Overholt BF, Panjehpour
M, Halberg DL. Photodynamic therapy for Barrett's esophagus with
dysplasia and /or early stage cancer. Gastrointestinal Endoscopy,
2003, 58(2); 183-8. |
|
Overholt BF, Panjehpour M, Haydek JM. Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointestinal Endoscopy 1999; 49(1):1-7. |
|
Patti MG, Corvera CU, Glasgow RE, Way LW. A hospital's annual rate of esophagectomy influences the operative mortality rate. J Gastrointest Surg 1998; 2(2):186-92. |
| Pech O, Gossner L, May
A, Rabenstein T, Vieth M, Stolte M, Berres M, Ell C. Long-term
results of photodynamic therapy with 5-aminolevulinic acid for
superficial Barrett's cancer and high-grade intraepithelial
neoplasia. Gastrointestinal Endoscopy 2005; 62 (1): 24-30. |
|
Peters JH, Clark GW, Ireland AP, Chandrasoma P, Smyrk TC, DeMeester TR. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg 1994; 108(5):813-21; discussion 821-2. |
|
Reid BJ, Blount PL, Feng Z, Levine DS. Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia. The American Journal of Gastroenterology 2000; 95(11):3089-96. |
|
Reid BJ, Levine DS, Longton G, Blount PL, Rabinovitch PS. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. American Journal of Gastroenterology 2000; 95(7):1669-76. |
|
Reid BJ, Weinstein WM, Lewin KJ, Haggitt RC, VanDeventer G, DenBesten L, Rubin CE. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology 1988; 94(1):81-90. |
|
Rusch VW, Levine DS, Haggitt R, Reid BJ. The management of high grade dysplasia and early cancer in Barrett's esophagus. A multidisciplinary problem. Cancer 1994; 74(4):1225-9. |
|
Sampliner RE, . Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. The American Journal of Gastroenterology 2002; 97(8):1888-95. |
|
Sampliner RE. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 1998; 93(7):1028-32. |
|
Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. The American Journal of Gastroenterology 2002; 97(8):1888-95. |
|
Schnell TG, Sontag SJ, Chejfec G, Aranha G, Metz A, O_Connell S, Seidel UJ, Sonnenberg A. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 2001; 120(7):1607-19. |
|
Selvasekar CR, Birbeck N, McMillan T, Wainwright M, Walker SJ. Photodynamic therapy and the alimentary tract. Alimentary Pharmacology & Therapeutics 2001; 15(7):899-915. |
|
Sontag S, Schnell T, Chejfec G, Kurucar C, O'Connell S, Levine G, Karpf J, Adelman K, Brand L, Seidel J. Barrett's, high grade dysplasia: surveillance endoscopy once a year is sufficient in most patients. Gastroenterology 1999; 116(4):A304-305. |
|
van den Boogert J, van Hillegersberg R, Siersema PD, de Bruin RW, Tilanus HW. Endoscopic ablation therapy for Barrett's esophagus with high-grade dysplasia: a review. American Journal of Gastroenterology 1999; 94(5):1153-60. |
|
Van Laethem JL, Peny MO, Salmon I, Cremer M, Deviere J. Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus. Gut 2000; 46(4):574-7. |
|
van Sandick JW, van Lanschot JJ, ten Kate FJ, Offerhaus GJ, Fockens P, Tytgat GN, Obertop H. Pathology of early invasive adenocarcinoma of the esophagus or esophagogastric junction: implications for therapeutic decision making. Cancer 2000; 88(11):2429-37. |
|
Wang KK. Current status of photodynamic therapy of Barrett's esophagus. Gastrointest Endosc 1999; 49(3 Pt 2):S20-3. |
|
Weston AP, Sharma P, Topalovski M, Richards R, Cherian R, Dixon A. Long-term follow-up of Barrett's high-grade dysplasia. American Journal of Gastroenterology 2000; 95(8):1888-93. |
|
Wright TA. High-grade dysplasia in Barrett's oesophagus. British Journal Of Surgery 1997; 84(6):760-6. |
|
